Tag Archives: Orphan Drug

March, 2017

November, 2016

  • 9 November

    FDA Grants Orphan Drug Designation to Eloxx’s Enzyme Deficiency Drug

    NESS ZIONA, Israel and WALTHAM, Massachusetts, November 7, 2016 /PRNewswire/ — Eloxx Pharmaceuticals, a biotechnology company focused on discovery, development and commercialization of compounds for the treatment of genetic diseases caused by nonsense mutations, announced today that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) …

October, 2016

August, 2016

May, 2016